Bergen, Norway, September 22, 2023: Lifecare AS (LIFE), a clinical stage medicalsensor company developing the next generation Continuous Glucose Monitor (CGM)will participate at Redeye Medtech & Diagnostics Seminar.
On 26 September at 1310 Lifecare will present latest developments from thecompany at the Redeye Medtech & Diagnostics Seminar. The presentation deck isenclosed. The presentation is live broadcasted and can be followed athttps://www.redeye.se/events/904816/redeye-theme-medtech-diagnostics-2 where thereplay and the presentations will be available afterwards.
Redeye Medtech & Diagnostics Seminar is scheduled from 09.00 to 15.10.
Lifecare AS is a clinical stage medical sensor company developing technology forsensing and monitoring of various body analytes. Lifecare's main focus is tobring the next generation of Continuous Glucose Monitoring ("CGM") systems tomarket. Lifecare enables osmotic pressure as sensing principle, combined withthe ability to manipulate Nano-granular Tunnelling Resistive sensors ("NTR") onthe sensor body for read-out of pressure variations. LifecareŽs sensortechnology is referred to as "Sencell" and is suitable for identifying andmonitoring the occurrence of a wide range of analytes and molecules in the humanbody.
For further information, please contact:
Joacim Holter, CEO, Lifecare AS, email@example.com, +47 40 05 90 40
Asle Wingsternes, Head of Communications & Public Affairs,firstname.lastname@example.org, +47 41 61 42 52